Both in Biotechnology
Kymera Therapeutics vs Halozyme Therapeutics
Over the past year KYMR returned +116.4% and HALO returned +96.5%; their daily moves had a correlation of 0.16.
KYMR +116.4% HALO +96.5%Growth of $1, one year, split-adjusted
| Metric | KYMR | HALO |
|---|---|---|
| Price | $129.23 | $130.06 |
| Market cap | $11.03B | $14.76B |
| Today | +1.35% | +0.86% |
| 1 month | +17.6% | +20.1% |
| 6 months | +56.2% | +97.4% |
| Year to date | +66.1% | +93.3% |
| 1 year | +109.0% | +99.5% |
| Revenue growth (YoY) | −100.0% | +47.7% |
| Gross margin | — | 83.5% |
| Net margin | — | 47.8% |
| P/E (TTM) | — | 35.7× |
| Price / sales | 107.9× | 8.9× |
| Net cash | $969.2M | -$1.92B |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 27.8% |
| Short % of float | 13.7% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).